Abstract:Background: Pharmacogenomics (PGx) aims to utilize a patient's genetic data to enable safer and more effective prescribing of medications. The Clinical Pharmacogenetics Implementation Consortium (CPIC) provides guidelines with strong evidence for 24 genes that affect 72 medications. Despite strong evidence linking PGx alleles to drug response, there is a large gap in the implementation and return of actionable pharmacogenetic findings to patients in standard clinical practice. In this study, we evaluated opportunities for genetically guided medication prescribing in a diverse health system and determined the frequencies of actionable PGx alleles in an ancestrally diverse biobank population. Methods: A retrospective analysis of the Penn Medicine electronic health records (EHRs), which includes ~ 3.3 million patients between 2012 and 2020, provides a snapshot of the trends in prescriptions for drugs with genotype-based prescribing guidelines ('CPIC level A or B') in the Penn Medicine health system. The Penn Medicine BioBank (PMBB) consists of a diverse group of 43,359 participants whose EHRs are linked to genome-wide SNP array and whole exome sequencing (WES) data. We used the Pharmacogenomics Clinical Annotation Tool (PharmCAT), to annotate PGx alleles from PMBB variant call format (VCF) files and identify samples with actionable PGx alleles. Results: We identified ~ 316.000 unique patients that were prescribed at least 2 drugs with CPIC Level A or B guidelines. Genetic analysis in PMBB identified that 98.9% of participants carry one or more PGx actionable alleles where treatment modification would be recommended. After linking the genetic data with prescription data from the EHR, 14.2% of participants (n = 6157) were prescribed medications that could be impacted by their genotype (as indicated by their PharmCAT report). For example, 856 participants received clopidogrel who carried CYP2C19 reduced function alleles, placing them at increased risk for major adverse cardiovascular events. When we stratified by genetic ancestry, we found disparities in PGx allele frequencies and clinical burden. Clopidogrel users of Asian ancestry in PMBB had significantly higher rates of CYP2C19 actionable alleles than European ancestry users of clopidrogrel (p < 0.0001, OR = 3.68). Conclusions: Clinically actionable PGx alleles are highly prevalent in our health system and many patients were prescribed medications that could be affected by PGx alleles. These results illustrate the potential utility of preemptive genotyping for tailoring of medications and implementation of PGx into routine clinical care.

A New Cloud-Native Tool for Pharmacogenetic Analysis

Pharmacogenomics Clinical Decision Support System:A Review

Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Building an Information System to Facilitate Pharmacogenomics Clinical Translation with Clinical Decision Support

PAnno: A Pharmacogenomics Annotation Tool for Clinical Genomic Testing

Pharmacogenomics, How to Deal with Different Types of Variants in Next Generation Sequencing Data in the Personalized Medicine Area

CLINICAL IMPLEMENTATION OF PREEMPTIVE PHARMACOGENOMICS TESTING FOR PERSONALIZED MEDICINE AT AN ACADEMIC MEDICAL CENTER

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population

Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations

GenoTools: An Open-Source Python Package for Efficient Genotype Data Quality Control and Analysis

Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences

Virtual Pharmacist: A Platform for Pharmacogenomics

An Integrated Bioinformatics Infrastructure Essential for Advancing Pharmacogenomics and Personalized Medicine in the Context of the FDA's Critical Path Initiative

Genomevip: A Cloud Platform For Genomic Variant Discovery And Interpretation

PGen: Large-Scale Genomic Variations Analysis Workflow and Browser in SoyKB

Empowering personalized pharmacogenomics with generative AI solutions

Rapid NGS Analysis on Google Cloud Platform: performance benchmark and user tutorial

SPANDx: a genomics pipeline for comparative analysis of large haploid whole genome re-sequencing datasets

Low-cost generation of clinical-grade layperson-friendly pharmacogenetic passports using oligonucleotide arrays

PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.

A high-performance computational workflow to accelerate GATK SNP detection across a 25-genome dataset